Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer

Alternate-day S-1 therapy appears to be a feasible and effective treatment option for frail patients with metastatic colorectal and pancreatic cancer. Continuous monitoring of the NLR and VES-13 scores can aid in the stratification of patients, ensuring that treatment intensity is appropriately matched to the patient's condition.

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2025-06-27
DOI
https://doi.org/10.21873/invivo.14044
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer

Junkichi Kanda, Masataka Sasaki, Naoki Odaira, Katsuki Muneoka
In Vivo
Colorectal Cancer Treatments and Studies
article

Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer

Junkichi Kanda, Masataka Sasaki, Naoki Odaira, Katsuki Muneoka
article en

Abstract

Alternate-day S-1 therapy appears to be a feasible and effective treatment option for frail patients with metastatic colorectal and pancreatic cancer. Continuous monitoring of the NLR and VES-13 scores can aid in the stratification of patients, ensuring that treatment intensity is appropriately matched to the patient's condition.

In VivoVol. 39(4)
Nagara Medical Center (JP)
Good health and well-being
Openalex Percentile: Top 77%
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer — Junkichi Kanda, Masataka Sasaki, et al. · In Vivo (2025) | TGRS Research Map | TGRS